ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,5,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
5,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
5,2,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
6,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
6,2,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
7,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
7,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
8,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
9,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
10,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
11,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
11,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
12,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
14,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
14,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
14,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,5,Mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,Y
14,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,7,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
14,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
15,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
18,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
18,3,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
19,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
20,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
21,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
22,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
22,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
22,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
22,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
22,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
23,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
23,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
24,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
24,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
24,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
26,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
27,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
27,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
27,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
27,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
27,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
28,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
28,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
30,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
30,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
30,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
30,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
30,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
30,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
30,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
32,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
34,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
36,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
37,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
37,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
38,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
38,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
39,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
40,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
40,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
40,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
41,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
41,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
41,4,Headache,Headaches NEC,Headaches,Nerv,N
41,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
41,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,7,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
41,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
42,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
43,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
43,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
43,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
43,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
44,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
44,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
44,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
44,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
45,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
47,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
47,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
47,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
48,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
49,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
50,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
51,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
52,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
52,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
52,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
53,2,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
53,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
53,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
53,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
54,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
54,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
54,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
55,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
55,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
56,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
56,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
56,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
57,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
57,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
58,1,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,Y
58,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
58,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
58,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
58,5,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
59,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
59,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
59,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
59,4,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
60,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
61,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
61,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
61,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
62,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
62,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
62,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
63,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
63,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
64,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
65,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
65,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
65,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
66,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
66,3,Pharyngeal inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
67,1,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
68,1,Radiation oesophagitis,Radiation injuries,Injuries by physical agents,Inj&P,N
69,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
69,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
69,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
69,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
70,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
70,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
71,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
71,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
71,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
71,5,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
71,6,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
71,7,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
71,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
72,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
72,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
72,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
73,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
74,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
74,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
74,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
74,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
75,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
76,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
76,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
77,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
77,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
77,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
77,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
77,5,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
77,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
79,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
79,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
79,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
79,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
79,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
79,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
79,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
80,1,Ventricular arrhythmia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
81,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
81,2,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
81,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
82,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
82,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
82,3,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
82,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
82,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
82,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
82,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
82,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
83,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
84,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
84,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
84,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
84,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
84,5,Pneumonia streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
85,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
86,1,Chronic cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
86,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
86,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
86,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
87,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
87,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
88,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
88,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
89,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
89,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
89,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
89,4,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
89,5,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
90,1,Infective exacerbation of chronic obstructive airways disease,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
90,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
90,3,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
91,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
91,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
92,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
92,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
92,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
93,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
94,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
94,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
95,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
95,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
96,1,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
96,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
97,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
98,1,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
98,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
99,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
99,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
99,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
99,5,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
99,6,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
99,7,Neurologic neglect syndrome,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
100,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
100,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
100,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
101,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
102,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
103,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
104,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
105,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
106,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
106,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
107,1,C-reactive protein decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
107,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
107,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
107,4,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
108,1,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
109,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
109,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
109,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
109,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
111,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
112,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
113,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
113,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
114,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
114,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
114,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
115,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
115,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
116,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
119,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
119,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
119,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
120,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
120,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
120,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
120,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
121,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
121,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
122,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
122,2,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
122,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
123,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
123,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
123,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
123,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
124,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
125,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
125,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
125,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
125,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
126,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
126,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
126,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
127,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
128,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
128,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
128,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
129,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
129,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
129,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
129,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
130,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
131,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
131,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
131,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
131,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
131,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
131,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
131,8,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
131,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
131,10,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
131,11,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
131,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
132,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
132,2,Vitamin B12 increased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
133,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
134,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
135,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
135,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
135,3,Tinea pedis,Tinea infections,Fungal infectious disorders,Infec,N
135,4,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
136,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
136,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
136,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
136,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
137,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
137,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
137,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
138,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
138,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
139,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
139,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
140,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
140,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
141,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
142,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
142,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
143,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
143,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
144,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
144,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
144,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
145,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
145,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
145,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
145,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
145,5,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
145,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
145,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
145,8,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
145,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,1,Blood folate decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
146,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
146,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
146,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
146,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
147,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
147,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
147,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
149,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
149,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
150,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,Y
151,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
152,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
153,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
153,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
153,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
155,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
155,2,Lung adenocarcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
155,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
155,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
155,5,Neuroendocrine carcinoma,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
155,6,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
155,7,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
155,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
156,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
156,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
158,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
158,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
158,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
158,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
158,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
159,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
159,2,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
160,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
160,2,Extremity necrosis,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
161,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
161,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
162,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
162,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
162,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
162,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
163,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
164,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
165,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
166,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
166,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
167,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
168,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
168,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
168,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
168,4,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
168,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
168,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
168,7,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
169,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
170,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
171,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
172,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
172,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
173,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
173,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
173,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
174,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
175,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
175,2,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
176,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
177,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
178,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
179,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
180,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
181,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
181,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
181,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
181,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
181,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
181,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
182,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
182,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
183,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
184,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
185,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
186,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
187,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
187,2,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
187,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
188,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
188,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
189,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
190,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
190,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
191,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
191,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
192,1,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
192,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
193,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
193,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
194,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
195,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
195,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
196,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
197,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
198,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,N
198,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
198,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
199,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
199,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
200,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
200,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
200,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
200,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
200,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
200,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
200,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
201,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
201,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
201,3,Headache,Headaches NEC,Headaches,Nerv,N
201,4,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
201,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
201,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
201,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
201,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
202,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
202,2,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
203,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
203,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
203,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
203,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
203,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
203,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
203,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
204,1,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
204,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
204,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
204,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
205,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
205,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
206,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
206,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
206,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
206,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
206,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
207,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
207,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
208,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
208,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
208,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
208,4,Non-small cell lung cancer metastatic,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
208,5,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
209,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
209,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
211,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
212,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
213,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
214,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
215,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
215,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
216,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
216,2,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
216,3,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
216,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
216,5,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
216,6,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
216,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
216,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
216,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
216,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
216,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
216,12,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
216,13,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
216,14,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
217,1,Obliterative bronchiolitis,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
217,2,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
217,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
218,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
219,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
219,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
220,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
221,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
221,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
221,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
221,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
221,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
222,1,Diverticulum intestinal,Diverticula,Diverticular disorders,Gastr,N
222,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
222,3,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
222,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
222,5,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
222,6,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
223,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
224,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
225,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
225,2,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
225,3,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
225,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
225,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
225,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
225,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
226,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
226,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
226,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
226,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
226,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
226,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
226,7,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
226,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
226,9,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
226,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
226,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
226,12,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
226,13,Headache,Headaches NEC,Headaches,Nerv,N
226,14,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
226,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
226,16,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
226,17,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
226,18,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
226,19,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
226,20,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
226,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
226,22,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
227,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
228,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
229,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
229,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
230,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
231,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
231,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
231,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
232,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
233,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
233,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
233,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
234,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
234,2,Blood urine,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
234,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
234,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
234,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
234,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
234,7,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
234,8,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
234,9,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
235,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
235,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
236,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
236,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
236,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
236,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
236,6,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,7,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
236,8,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
236,9,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
236,10,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
236,11,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
236,12,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
236,13,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
236,14,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
236,15,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
236,16,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
236,17,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
236,18,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
236,19,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
236,20,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
236,21,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
236,22,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
236,23,Headache,Headaches NEC,Headaches,Nerv,N
236,24,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
236,25,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
236,26,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
236,27,Joint deposit,Joint related disorders NEC,Joint disorders,Musc,N
236,28,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
236,29,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
236,30,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
236,31,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,32,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,33,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,34,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,35,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
236,36,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
236,37,Oral mucosal roughening,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
236,38,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
236,39,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
236,40,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
236,41,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
236,42,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
236,43,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
236,44,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,45,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,46,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
236,47,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
236,48,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
236,49,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
236,50,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
236,51,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
236,52,Urinary tract obstruction,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
236,53,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
236,54,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
237,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
237,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
237,3,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
238,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
239,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
239,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
240,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
240,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
240,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
240,4,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
241,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
241,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
241,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
241,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
242,1,Lung adenocarcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
243,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
243,2,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
243,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
243,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
244,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
244,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
244,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
245,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
245,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
246,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
247,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
247,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
248,2,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
249,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
249,2,Lymphangiosis carcinomatosa,Metastases to specified sites,Metastases,Neopl,N
249,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
250,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
251,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
251,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
252,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
252,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
252,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
253,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
254,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
254,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
254,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
255,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
256,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
257,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
258,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
258,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
258,3,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
258,4,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
259,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
259,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
260,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
261,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
262,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
263,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
264,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
264,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
265,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
265,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
265,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
265,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
266,1,Headache,Headaches NEC,Headaches,Nerv,N
266,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
266,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
267,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
268,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
268,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
269,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
269,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
269,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
269,4,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
269,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
270,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
271,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
271,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
271,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
272,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
272,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
272,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
273,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
273,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
273,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
273,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
273,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
273,6,Renal tubular injury,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
273,7,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
274,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
274,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
274,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
274,4,Nephritis,Nephritis NEC,Nephropathies,Renal,N
275,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
276,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
276,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
276,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
276,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
277,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
278,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
278,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
278,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
279,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
279,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
279,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
280,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
280,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
281,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
282,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
282,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
283,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
284,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
285,1,Renal tubular injury,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
285,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
286,1,Renal tubular injury,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
287,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
288,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
289,1,Epithelioid mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
289,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
289,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
290,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
291,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
292,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
292,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
293,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
293,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
293,3,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
294,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
294,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
295,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
295,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
295,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
296,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
296,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
297,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
298,1,Malignant pleural effusion,Pleural neoplasms,Pleural disorders,Resp,N
298,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
299,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
300,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
301,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
301,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
302,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
302,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
303,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
304,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
304,2,Lung adenocarcinoma stage IV,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
304,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
304,4,Metastases to uterus,Metastases to specified sites,Metastases,Neopl,N
305,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
305,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
306,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
306,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
306,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
307,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
307,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
308,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
308,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
309,1,Epithelioid mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,N
309,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
309,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
309,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
311,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
311,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
311,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
312,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
312,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
313,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
313,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
313,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
313,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
313,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
313,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
313,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
313,8,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
314,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
314,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
314,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
315,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
315,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
315,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
316,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
316,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
316,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
317,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
317,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
318,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
319,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
319,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
320,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
320,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
320,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
321,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
322,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
322,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
323,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
323,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
324,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
325,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
325,2,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
325,3,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
326,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
326,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
327,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
328,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
328,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
328,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
328,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
329,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
329,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
329,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
329,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
329,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
329,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
330,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
330,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
330,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
331,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
331,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
332,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
332,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
333,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
333,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
333,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
333,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
334,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
334,2,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
335,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
335,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
335,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
336,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
336,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
336,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
336,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
337,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
337,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
338,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
338,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
339,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
339,3,Renal vein thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
340,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
340,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
341,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
342,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
342,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
343,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
343,4,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
344,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
344,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
344,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
345,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
346,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
346,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
346,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
346,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
346,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
347,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
348,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
348,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
348,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
348,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
348,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
350,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
350,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
350,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
351,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
351,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
351,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
351,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
351,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
351,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
352,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
353,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
353,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
353,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
353,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
354,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
354,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
354,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
354,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
354,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
354,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
355,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
356,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
356,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
356,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
357,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
357,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
357,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
358,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
358,2,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
359,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
359,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
359,3,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
360,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
361,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
362,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
363,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
363,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
363,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
363,4,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,N
364,1,Insurance issue,Economic circumstances,Economic and housing issues,SocCi,N
364,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
364,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
364,4,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
365,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
366,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
366,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
368,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
369,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
370,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
371,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
371,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
372,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
373,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
373,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
374,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
375,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
375,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
375,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
376,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
376,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
